Pharvaris PHVS Institutional Ownership

Pharvaris N.V. (NASDAQ:PHVS) showed up in the 13F filings of 125 institutional investors as of June 2026.

• These investors collectively held 109.0% of Pharvaris's outstanding shares in June 2026, up from 99.6% in March 2026.
• They increased total shares held in Pharvaris by 11.35% from the prior quarter, while the number of investors in PHVS increased 115.52% year over year.
• Activity in PHVS broke down as 73 buyers, 33 sellers, and 19 unchanged among 125 total holders.
• Institutional investors collectively held 64.51Mn shares in Pharvaris as of June 2026, up by 6.57Mn shares quarter on quarter, and up 19.74Mn shares year over year.
• FMR LLC is the top holder of Pharvaris as of June 30, 2026, with 6.57Mn shares representing 11.1% of outstanding stock.
• The largest buyers of Pharvaris for the quarter ending June 2026 were Polar Capital Holdings Plc (1.55Mn), TCG Crossover Management, LLC (1.01Mn), Point72 Asset Management, L.P. (634.18K), Seven Fleet Capital Management LP (601.77K), Jones Hill Capital LP (510.86K).
• The biggest sellers of Pharvaris for the quarter ending June 2026 included GENERAL ATLANTIC, L.P. (1.48Mn), Commodore Capital LP (493.97K), Novo Holdings A/S (350.0K), Cormorant Asset Management, LP (250.0K), Ikarian Capital, LLC (178.0K).
• Business Quant data shows the 10 biggest positions in Pharvaris as of June 2026 are held by FMR LLC (6.57Mn), GENERAL ATLANTIC, L.P. (6.55Mn), Foresite Capital Management IV, LLC (4.78Mn), venBio Partners LLC (4.64Mn), VIKING GLOBAL INVESTORS LP (3.65Mn), EQT Fund Management S.a r.l. (3.42Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (3.38Mn), Bain Capital Life Sciences Investors, LLC (2.68Mn), WELLINGTON MANAGEMENT GROUP LLP (2.39Mn), Polar Capital Holdings Plc (2.33Mn).